echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Prospective Industrial Research Institute: Top 10 biopharmaceutical companies in China in 2014

    Prospective Industrial Research Institute: Top 10 biopharmaceutical companies in China in 2014

    • Last Update: 2014-08-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: prospective.com August 13, 2014, biomedical industry is one of the economic fields with the best growth and the most active development in China in recent years Therefore, all over the country are vigorously promoting its development, and the "single spark" of the biomedical industry is showing a prairie fire in China After more than 10 years of efforts, China has basically established an innovative drug incubation base with enterprises as the main body, which has improved the level of drug research and development and industrialization; initially formed a specialized new drug research and development team with a certain scale, and enhanced the technological innovation ability of enterprises In the 12th Five Year Plan, the key development direction and products of biopharmaceutical industry include genetic engineering drugs, development of active protein and polypeptide drugs, extraction of Chinese herbal medicine and its effective bioactive components, fermentation production, development of various vaccines, monoclonal antibodies and enzyme diagnostic and therapeutic reagents, and development of targeted drugs With the rapid and stable growth of new product R & D expenditure, the scale of production and marketing of new products of large and medium-sized enterprises in China's biopharmaceutical industry showed a rapid growth trend from 2000 to 2011 In 2011, the output value of new products of large and medium-sized enterprises in the industry reached 21.547 billion yuan, a year-on-year growth of 47.35%, with a compound growth rate of 30.25% in 2000-2011; the sales revenue of new products was 20.481 billion yuan, a year-on-year growth of 47.59%, with a compound growth rate of 32.09% in 2000-2011 According to the statistical data of "2014-2018 China biopharmaceutical industry technology research and development and new product listing analysis report" issued by prospective industry research institute, the top ten Biopharmaceutical Enterprises in China in 2014 are as follows (ranking in no particular order):
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.